Owner Abbott GmbH & Co. KG

Inventors Sakorafas, Paul; Friedrich, Stuart; Venturini, Amy; Du Fou, Sarah L.; Salfeld, Jochen G; Banerjee, Subhashis; Myles, Angela; Widom, Angela; Veldman, Geertruida M; Derbyshire, Elaine J.; Roguska, Michael; Tracey, Daniel E; Paskind, Michael; Holtet, Thor Las; Kaymakcalan, Zehra; Carmen, Sara; Smith, Stephen; Duncan, Alexander R.; Warne, Nicholas W; White, Michael; Elvin, John G.; Labkovsky, Boris

Agent Spruson & Ferguson

Pub. Number AU-B-2006225302

Parent 2005200515

Filing date 6 October 2006

Wipo publication date 26 October 2006

Acceptance publication date 12 August 2010

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies